"Together we're transforming wound and lymphoedema care We have a clear vision at Accelerate – to boldly transform chronic wound, lymphoedema and mobility outcomes and to make sure we engage our patients in their personal journey, every step of the way. We know that to achieve this we need to continue to develop and increase access to our world-class treatments and thinking in lower limb management and wider issues around lymphoedema and chronic wounds. We are committed to ensuring that we work with our patients to enable them to both understand their condition and begin to embrace self-management"

During the past decade, Accelerate CIC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Accelerate CIC" are "Venous Leg Ulcer" (2 trials), "Leg Ulcer" (1 trials), "Leg Ulcers Venous" (1 trials), "Wound" (1 trials) and "Wound Leg" (1 trials). Many other conditions were trialed in "Accelerate CIC" in a lesser frequency.

Most popular intervention types in "Accelerate CIC" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Venous Leg Ulcer Standard of Care with Granulox" (1 trials) and "geko™ medical device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Accelerate CIC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Accelerate CIC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Accelerate CIC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Accelerate CIC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".